HHL.TO
Harvest Healthcare Leaders Income ETF
International
EQUITY
Active
MANAGEMENT STYLE
$ 1.9 B
ASSETS UNDER MGMT
85 bp
EXPENSES
Fund Basics
| Inception date | Nov 19, 2014 |
| Regulation | |
| Fund Website | link... |
| Distributions | |
| Currency | CAD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| ELI LILLY & CO | 5.6 % |
| UNITEDHEALTH GROUP INC | 5.3 % |
| ELEVANCE HEALTH INC | 5.3 % |
| ABBVIE INC | 5.1 % |
| NOVARTIS AG-ADR | 5.1 % |
| ASTRAZENECA PLC | 5.0 % |
| MERCK & CO. INC. | 5.0 % |
| JOHNSON & JOHNSON | 4.9 % |
| REGENERON PHARMACEUTICALS | 4.9 % |
| AGILENT TECHNOLOGIES INC | 4.8 % |
Constituent Breakdown
| Number of holdings | 24 |
| Herfindahl-Hirschman Index | 470 |
| Wgt avg mkt cap (mns) | $239,747 |
| Large cap (>$10bn) | 96.8% |
| Mid cap ($2-10bn) | 0.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 96.8% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 82.1 % |
 |
SWITZERLAND | 5.1 % |
 |
BRITAIN | 5.0 % |
 |
IRELAND | 4.7 % |
Historical Performance
Standardized Performance (as of 05/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -10.7% | -3.8% | -8.6% | -4.3% | -3.5% | -2.2% | -- | -3.1% |
| Dividend Yield | 3.0% | 9.1% | 8.6% | 8.9% | 8.8% | 8.9% | -- | 8.7% |
| Total Returns | -7.7% | 5.3% | 0.0% | 4.5% | 5.3% | 6.7% | -- | 5.5% | Ann. Volatility | 13.9% | 14.0% | 14.6% | 13.3% | 14.0% | 15.8% | -- | 16.5% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.50 | 17% |
| MSCI EAFE | 0.50 | 29% |
| MSCI Emg Mkts | 0.24 | 12% |
Liquidity Measures
| Avg. volume (000) | 466 |
| ADV traded (mns) | $3 |
| Turnover | 0.2% |
| Avg. Bid/Ask (% of price) | 0.00% |
Technical Indicators
| 30d moving avg. (EMA) | $6.91 |
| Relative strength (RSI) | 46 |
| MACD/Signal | -0.01/-0.03 |
| Bollinger Bands (Upper/Lower) | $6.98/$6.72 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. HHL.TO |
Expenses vs. HHL.TO |
ALTAR Score™ vs. HHL.TO |
|---|---|---|---|---|
| LMAX.TO | Hamilton Healthcare YIELD MAXIMIZER TM ETF | 71.0% | -20 bp | +0.5% |
| MEDX.TO | Global X Equal Weight Global Healthcare Index ETF | 66.1% | -45 bp | +1.0% |
| HIG.TO | Brompton Global Healthcare Income & Growth ETF | 59.2% | -10 bp | +0.3% |
| MHCD.TO | Middlefield Healthcare Dividend ETF | 53.8% | 0 bp | -1.2% |
| TDOC.TO | TD Global Healthcare Leaders Index ETF | 35.9% | -50 bp | +0.5% |
| ZUH.TO | BMO Equal Weight US Health Care Hedged to CAD Index ETF | 22.7% | -50 bp | -1.0% |
| ZHU.TO | BMO Equal Weight US Health Care Index ETF | 22.2% | -50 bp | -1.3% |
| FHH.TO | First Trust AlphaDEX U.S. Health Care Sector Index ETF | 17.9% | -9 bp | +1.1% |
| XDU.TO | iShares Core MSCI US Quality Dividend Index ETF | 16.7% | -69 bp | +0.1% |
| XHD.TO | iShares U.S. High Dividend Equity Index ETF (CAD-Hedged) | 15.5% | -52 bp | -0.3% |
Risk and Returns: HHL.TO vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (CAD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 6/18/2026
Peer Group Comparison
Sample data. Subscribe for access.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.8%
ALTAR SCORE™
66th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 417 funds in the International Equity category with an average
ALTAR Score™ of 6.1% and a standard deviation
of 1.6%. HHL.TO's ALTAR Score™ is approximately 0.4 standard
deviations above the category average. This places HHL.TO in the 66th percentile
among funds in the category.
Sell-Side Consensus
$8.4
PRICE TARGET
+22.8%
UPSIDE